Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B.

Cheng P, Chen C, He HB, Hu R, Zhou HD, Xie H, Zhu W, Dai RC, Wu XP, Liao EY, Luo XH.

J Bone Miner Res. 2013 May;28(5):1180-90. doi: 10.1002/jbmr.1845.

2.

MiR-503 regulates osteoclastogenesis via targeting RANK.

Chen C, Cheng P, Xie H, Zhou HD, Wu XP, Liao EY, Luo XH.

J Bone Miner Res. 2014 Feb;29(2):338-47. doi: 10.1002/jbmr.2032.

3.

MiR-125a TNF receptor-associated factor 6 to inhibit osteoclastogenesis.

Guo LJ, Liao L, Yang L, Li Y, Jiang TJ.

Exp Cell Res. 2014 Feb 15;321(2):142-52. doi: 10.1016/j.yexcr.2013.12.001. Epub 2013 Dec 17.

PMID:
24360988
4.

A novel microRNA regulates osteoclast differentiation via targeting protein inhibitor of activated STAT3 (PIAS3).

Liu T, Qin AP, Liao B, Shao HG, Guo LJ, Xie GQ, Yang L, Jiang TJ.

Bone. 2014 Oct;67:156-65. doi: 10.1016/j.bone.2014.07.004. Epub 2014 Jul 12.

PMID:
25019593
6.

The role of microRNAs in osteoclasts and osteoporosis.

Tang P, Xiong Q, Ge W, Zhang L.

RNA Biol. 2014;11(11):1355-63. doi: 10.1080/15476286.2014.996462. Review.

7.

MafB negatively regulates RANKL-mediated osteoclast differentiation.

Kim K, Kim JH, Lee J, Jin HM, Kook H, Kim KK, Lee SY, Kim N.

Blood. 2007 Apr 15;109(8):3253-9. Epub 2006 Dec 7.

8.

BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.

Valverde P, Tu Q, Chen J.

J Bone Miner Res. 2005 Sep;20(9):1669-79. Epub 2005 May 16.

9.

Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.

Roato I, Porta F, Mussa A, D'Amico L, Fiore L, Garelli D, Spada M, Ferracini R.

PLoS One. 2010 Nov 30;5(11):e14167. doi: 10.1371/journal.pone.0014167.

10.

RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.

Iwai K, Koike M, Ohshima S, Miyatake K, Uchiyama Y, Saeki Y, Ishii M.

J Bone Miner Res. 2007 Oct;22(10):1612-20.

11.

A microRNA expression signature of osteoclastogenesis.

Sugatani T, Vacher J, Hruska KA.

Blood. 2011 Mar 31;117(13):3648-57. doi: 10.1182/blood-2010-10-311415. Epub 2011 Jan 27.

12.

Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.

Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.

Biochem Biophys Res Commun. 2005 Apr 15;329(3):839-45.

PMID:
15752732
13.

Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB.

Smink JJ, Bégay V, Schoenmaker T, Sterneck E, de Vries TJ, Leutz A.

EMBO J. 2009 Jun 17;28(12):1769-81. doi: 10.1038/emboj.2009.127. Epub 2009 May 14.

14.

Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.

Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M.

J Bone Miner Res. 2011 Mar;26(3):644-56. doi: 10.1002/jbmr.242.

15.

T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients.

Brunetti G, Colucci S, Pignataro P, Coricciati M, Mori G, Cirulli N, Zallone A, Grassi FR, Grano M.

J Periodontol. 2005 Oct;76(10):1675-80.

PMID:
16253089
16.

Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes.

Shinoda K, Sugiyama E, Taki H, Harada S, Mino T, Maruyama M, Kobayashi M.

Bone. 2003 Oct;33(4):711-20.

PMID:
14555277
18.

Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL).

Nicholson GC, Malakellis M, Collier FM, Cameron PU, Holloway WR, Gough TJ, Gregorio-King C, Kirkland MA, Myers DE.

Clin Sci (Lond). 2000 Aug;99(2):133-40.

PMID:
10918046
19.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
20.

Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor.

Kaneda T, Nojima T, Nakagawa M, Ogasawara A, Kaneko H, Sato T, Mano H, Kumegawa M, Hakeda Y.

J Immunol. 2000 Oct 15;165(8):4254-63.

Supplemental Content

Support Center